ADVFN Logo
Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
Regeneron Pharmaceuticals Inc

Regeneron Pharmaceuticals Inc (1REGN)

647.60
0.00
(0.00%)
Closed February 25 11:30AM

Regeneron Pharmaceuticals Inc Financial Summary

The current 1REGN market cap is 70.8B. The company's latest EPS is USD 40.3623 and P/E is 17.92.

Year End December 30 2024 20202021202220232024
USD ($)USD ($)USD ($)USD ($)USD ($)
Total Revenue 8.78B16.12B12.26B13.12B14.2B
Operating Income 3.58B8.95B4.74B4.05B3.99B
Net Income 3.51B8.08B4.34B3.95B4.41B
Year End December 30 2024 20202021202220232024
USD ($)USD ($)USD ($)USD ($)USD ($)
Total Assets 17.16B25.43B29.21B33.08B37.76B
Total Liabilities 6.14B6.67B6.55B7.11B8.41B
Total Equity 11.03B18.77B22.66B25.97B29.35B

Cash Flow

Year End December 30 2024 20202021202220232024
USD ($)USD ($)USD ($)USD ($)USD ($)
Operating 2.62B7.08B5.01B4.59B4.42B
Investing -70.6M-5.38B-3.78B-3.19B-2.47B
Financing -1.97B-1.01B-1.01B-1.79B-2.2B
Market Cap 70.8B
Price to Earnings Ratio 17.92
Price to Sales Ratio 5.57
Price to Cash Ratio 31.79
Price to Book Ratio 2.69
Dividend Yield 0.14%

Share Statistics

Shares Outstanding 109.32M
Average Volume (1 week) 0
Average Volume (1 Month) 11
52 Week Change -29.91%
52 Week High 1,094.50
52 Week Low 647.60
Spread (Intraday) 3.2 (0.46%)

Company Info

Company Name Regeneron Pharmaceuticals Inc
Address 28 liberty street
new york, new york 10005
Website https://www.regeneron.com
Industry health care diversified (H)

Your Recent History

Delayed Upgrade Clock